Review highlights stereotactic body radiotherapy's efficacy in local control and survival in renal cancer, suggesting it may replace surgery.
Article presents a review of the current state of stereotactic body radiotherapy (SBRT) in the treatment of renal cell carcinoma. The analysis includes recent retrospective and prospective studies, including data from leading international multicenter consortia. SBRT demonstrates high efficacy in terms of local control and overall survival, as well as good tolerability and preservation of renal function, particularly in functionally inoperable patients. The evidence suggests that SBRT may serve as a promising alternative to surgery in selected cases.
No takes yet. Share an insight, caveat, or question.
Kornilov et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: